AXCELLA HEALTH INC. Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2023-06-30..
Operating margin
Overview →Financial period ending 2023-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2023-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -45.77M USD | Operating Income (Loss) |
| Revenue | (m) | |
| Cost of products and services | (m) | |
| Research and development | 29.23M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2023-06-30 | $-45.77M | (m) | (m) | $29.23M | (m) | (m) |
| 2023-03-31 | $-62.84M | (m) | (m) | $44.87M | (m) | (m) |
| 2022-12-31 | $-76.99M | (m) | (m) | $56.98M | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $-71.06M | (m) | (m) | $53.01M | (m) | (m) |
| 2022-03-31 | $-65.68M | (m) | (m) | $46.44M | (m) | (m) |
| 2021-12-31 | $-61.85M | (m) | (m) | $43.13M | (m) | (m) |
| 2021-09-30 | $-59.11M | (m) | (m) | $41.27M | (m) | (m) |
| 2021-06-30 | $-55.93M | (m) | (m) | $38.68M | (m) | (m) |
| 2021-03-31 | $-53.87M | (m) | (m) | $36.94M | (m) | (m) |
| 2020-12-31 | $-53.84M | (m) | (m) | $37.04M | (m) | (m) |
| 2020-09-30 | $-54.71M | (m) | (m) | $39.04M | (m) | (m) |
| 2020-06-30 | $-59.98M | (m) | (m) | $43.65M | (m) | (m) |
| 2020-03-31 | $-60.87M | (m) | (m) | $44.43M | (m) | (m) |
| 2019-12-31 | $-57.44M | (m) | (m) | $41.66M | (m) | (m) |
| 2019-09-30 | $-51.26M | (m) | (m) | $36.94M | (m) | (m) |
| 2019-06-30 | $-42.50M | (m) | (m) | $30.93M | (m) | (m) |
| 2019-03-31 | $-37.34M | (m) | (m) | $27.59M | (m) | (m) |
| 2018-12-31 | $-33.90M | (m) | (m) | $25.49M | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.